H. Şentürk Çiftçi Et Al. , "CYP3A5 gene polymorphism is associated with risk of acute rejection incyclosporine treated in Turkish renal transplant patients," 5. 6th Santorini Conference Biologie Prospective 2012 , Trikala, Greece, pp.30, 2012
Şentürk Çiftçi, H. Et Al. 2012. CYP3A5 gene polymorphism is associated with risk of acute rejection incyclosporine treated in Turkish renal transplant patients. 5. 6th Santorini Conference Biologie Prospective 2012 , (Trikala, Greece), 30.
Şentürk Çiftçi, H., Çalışkan, Y. K., Günay, I., Ayna, T. K., Bakkaloğlu, H., Nane, İ., ... Aydın, A. E.(2012). CYP3A5 gene polymorphism is associated with risk of acute rejection incyclosporine treated in Turkish renal transplant patients . 5. 6th Santorini Conference Biologie Prospective 2012 (pp.30). Trikala, Greece
Şentürk Çiftçi, Hayriye Et Al. "CYP3A5 gene polymorphism is associated with risk of acute rejection incyclosporine treated in Turkish renal transplant patients," 5. 6th Santorini Conference Biologie Prospective 2012, Trikala, Greece, 2012
Şentürk Çiftçi, Hayriye Ş. Et Al. "CYP3A5 gene polymorphism is associated with risk of acute rejection incyclosporine treated in Turkish renal transplant patients." 5. 6th Santorini Conference Biologie Prospective 2012 , Trikala, Greece, pp.30, 2012
Şentürk Çiftçi, H. Et Al. (2012) . "CYP3A5 gene polymorphism is associated with risk of acute rejection incyclosporine treated in Turkish renal transplant patients." 5. 6th Santorini Conference Biologie Prospective 2012 , Trikala, Greece, p.30.
@conferencepaper{conferencepaper, author={Hayriye ŞENTÜRK ÇİFTÇİ Et Al. }, title={CYP3A5 gene polymorphism is associated with risk of acute rejection incyclosporine treated in Turkish renal transplant patients}, congress name={5. 6th Santorini Conference Biologie Prospective 2012}, city={Trikala}, country={Greece}, year={2012}, pages={30} }